Astrana Health, Inc. (ASTH)
31.80
+0.03
(+0.09%)
USD |
NASDAQ |
Nov 13, 16:00
31.79
-0.01
(-0.03%)
After-Hours: 19:59
Astrana Health Enterprise Value : 1.922B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.922B |
| November 12, 2026 | 1.921B |
| November 11, 2026 | 1.978B |
| November 10, 2026 | 1.941B |
| November 09, 2026 | 2.019B |
| November 06, 2026 | 2.055B |
| November 05, 2026 | 2.278B |
| November 04, 2026 | 2.310B |
| November 03, 2026 | 2.165B |
| November 02, 2026 | 2.173B |
| October 30, 2026 | 2.155B |
| October 29, 2026 | 2.160B |
| October 28, 2026 | 2.162B |
| October 27, 2026 | 2.176B |
| October 26, 2026 | 2.190B |
| October 23, 2026 | 2.201B |
| October 22, 2026 | 2.228B |
| October 21, 2026 | 2.196B |
| October 20, 2026 | 2.257B |
| October 19, 2026 | 2.174B |
| October 16, 2026 | 2.169B |
| October 15, 2026 | 2.229B |
| October 14, 2026 | 2.214B |
| October 13, 2026 | 2.222B |
| October 12, 2026 | 2.248B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.206B |
| October 08, 2026 | 2.123B |
| October 07, 2026 | 2.186B |
| October 06, 2026 | 2.179B |
| October 05, 2026 | 2.169B |
| October 02, 2026 | 2.123B |
| October 01, 2026 | 2.076B |
| September 30, 2026 | 2.108B |
| September 29, 2026 | 2.091B |
| September 28, 2026 | 2.075B |
| September 25, 2026 | 2.136B |
| September 24, 2026 | 2.041B |
| September 23, 2026 | 2.036B |
| September 22, 2026 | 2.074B |
| September 21, 2026 | 1.997B |
| September 18, 2026 | 2.037B |
| September 17, 2026 | 2.034B |
| September 16, 2026 | 2.201B |
| September 15, 2026 | 2.233B |
| September 14, 2026 | 2.295B |
| September 11, 2026 | 2.215B |
| September 10, 2026 | 2.218B |
| September 09, 2026 | 2.219B |
| September 08, 2026 | 2.221B |
| September 04, 2026 | 2.239B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilon Health, Inc. | 1.664B |
| Starling Oncology, Inc. | 422.80M |
| Nakamoto, Inc. | 237.18M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 59.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.27M |
| Revenue (Quarterly) | 1.024B |
| Total Expenses (Quarterly) | 1.011B |
| EPS Diluted (Quarterly) | 0.2595 |
| Gross Profit Margin (Quarterly) | 10.54% |
| Profit Margin (Quarterly) | 1.98% |
| Earnings Yield | 3.37% |
| Operating Earnings Yield | 7.68% |
| Normalized Earnings Yield | 3.028 |